Cargando…
Metabolic biomarkers for response to PI3K inhibition in basal-like breast cancer
INTRODUCTION: The phosphatidylinositol 3-kinase (PI3K) pathway is frequently activated in cancer cells through numerous mutations and epigenetic changes. The recent development of inhibitors targeting different components of the PI3K pathway may represent a valuable treatment alternative. However, p...
Autores principales: | Moestue, Siver A, Dam, Cornelia G, Gorad, Saurabh S, Kristian, Alexandr, Bofin, Anna, Mælandsmo, Gunhild M, Engebråten, Olav, Gribbestad, Ingrid S, Bjørkøy, Geir |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3672699/ https://www.ncbi.nlm.nih.gov/pubmed/23448424 http://dx.doi.org/10.1186/bcr3391 |
Ejemplares similares
-
Distinct choline metabolic profiles are associated with differences in gene expression for basal-like and luminal-like breast cancer xenograft models
por: Moestue, Siver A, et al.
Publicado: (2010) -
Anti-vascular effects of the cytosolic phospholipase A2 inhibitor AVX235 in a patient-derived basal-like breast cancer model
por: Kim, Eugene, et al.
Publicado: (2016) -
Intravascular Targets for Molecular Contrast-Enhanced Ultrasound Imaging
por: Moestue, Siver A., et al.
Publicado: (2012) -
Interplay of choline metabolites and genes in patient-derived breast cancer xenografts
por: Grinde, Maria T, et al.
Publicado: (2014) -
Biodistribution of Poly(alkyl cyanoacrylate) Nanoparticles in Mice and Effect on Tumor Infiltration of Macrophages into a Patient-Derived Breast Cancer Xenograft
por: Pandya, Abhilash D., et al.
Publicado: (2021)